Table 3. CI-AKI incidence and Clinical outcomes in-hospital.

Outcomes	Urinary Albumin				p
	All (N = 597)	Negative (N = 483)	Trace (N = 60)	Positive (N = 54)
CI-AKI
SCr increase≥26.4µmol/L or ≥50%, n(%)	33(5.5%)	19(3.9%)	4(6.7%)	10(18.5%)	<0.001
SCr increase≥26.4µmol/L, n(%)	31(5.2%)	18(3.7%)	3(5.0%)	10(18.5%)	<0.001
SCr increase≥50%, n(%)	10(1.7%)	6(1.2%)	2(3.3%)	2 (3.7%)	0.101
Absolute change in SCr, µmol/L	1.3(−5.8–10.0)	0.9(−5.5–9.0)	2.3(−6.0–10.0)	10.1(−7.8–20.1)	0.016*
Death, n(%)	3 (0.5%)	1(0.2%)	2(3.3%)	0(0%)	0.280
Dialysis, n(%)	2(0.5%)	0(0%)	1(1.7%)	1(1.9%)	0.005

CI-AKI: contrast-induced acute kidney injury; SCr: serum creatinine;

^* P was tested by Kruskal-Wallis test.